Biotricity Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Waqaas Al-Siddiq

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage38.3%
CEO tenure10yrs
CEO ownership3.6%
Management average tenure6.8yrs
Board average tenure6.9yrs

Recent management updates

Recent updates

Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding

Jan 26
Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding

Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)

Oct 26
Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)

Biotricity GAAP EPS of -$0.09, revenue of $2.06M

Aug 15

Biotricity, Inc.: A First Take

Jul 28

Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?

Apr 09
Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?

Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?

Dec 11
Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?

Biotricity: Capital Raise Leads To Buying Opportunity

Aug 31

CEO Compensation Analysis

How has Waqaas Al-Siddiq's remuneration changed compared to Biotricity's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024US$1mUS$480k

-US$15m

Dec 31 2023n/an/a

-US$15m

Sep 30 2023n/an/a

-US$17m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023US$1mUS$480k

-US$20m

Dec 31 2022n/an/a

-US$21m

Sep 30 2022n/an/a

-US$23m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022US$887kUS$480k

-US$30m

Dec 31 2021n/an/a

-US$30m

Sep 30 2021n/an/a

-US$27m

Jun 30 2021n/an/a

-US$19m

Mar 31 2021US$891kUS$390k

-US$16m

Dec 31 2020n/an/a

-US$16m

Sep 30 2020n/an/a

-US$14m

Jun 30 2020n/an/a

-US$13m

Mar 31 2020US$2mUS$390k

-US$11m

Dec 31 2019n/an/a

-US$8m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$8m

Mar 31 2019US$2mUS$360k

-US$9m

Dec 31 2018n/an/a

-US$10m

Sep 30 2018n/an/a

-US$9m

Jun 30 2018n/an/a

-US$9m

Mar 31 2018US$1mUS$310k

-US$9m

Compensation vs Market: Waqaas's total compensation ($USD1.25M) is above average for companies of similar size in the US market ($USD687.60K).

Compensation vs Earnings: Waqaas's compensation has increased whilst the company is unprofitable.


CEO

Waqaas Al-Siddiq (39 yo)

10yrs

Tenure

US$1,254,153

Compensation

Dr. Waqaas Al-Siddiq, PhD, has founded Biotricity Inc.(formerly known as iMedical Innovations Inc.) in July 2014 and has been its Chairman, President and Chief Executive Officer since July 2014. Dr. Al-Sid...


Leadership Team

NamePositionTenureCompensationOwnership
Waqaas Al-Siddiq
Founder10yrsUS$1.25m3.61%
$ 692.4k
S. Ayanoglou
Chief Financial Officer6.8yrsUS$562.00k1.26%
$ 241.7k
Amjad Talpur
Senior Director of Operationsno datano datano data
George Nikopoulos
Director of Business Developmentno datano datano data
Matt Zabel
Vice President of Sales & Strategyno datano datano data
Amir Ali
Chief Development Officerno datano datano data
Fareeha Siddiqui
Senior Vice President of Healthcare Solutionsless than a yearno datano data

6.8yrs

Average Tenure

Experienced Management: BTCY's management team is seasoned and experienced (6.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Waqaas Al-Siddiq
Founder10yrsUS$1.25m3.61%
$ 692.4k
John Simpson
Chair of Scientific & Medical Alliance Board and Chair of Science Alliance Board4.3yrsno datano data
Daniel Sands
Member of the Board of Advisors8.2yrsno datano data
Ronald McClurg
Independent Director2.2yrsUS$32.62k0.16%
$ 31.2k
David Rosa
Independent Director8.2yrsUS$60.00k1.38%
$ 263.9k
J. Rice
Member of the Board of Advisors8.1yrsno datano data
John Rother
Member of the Board of Advisors8.2yrsno datano data
Thomas Nelson
Member of the Board of Advisors8.1yrsno datano data
Donald Cross
Member of Scientific & Medical Alliance Board5.7yrsno datano data
Edward Lazaga
Member of Scientific & Medical Alliance Board5.7yrsno datano data
Imran Mohiuddin
Member of Scientific & Medical Alliance Board5.7yrsno datano data
Radoslaw Kiesz
Member of Scientific & Medical Alliance Board5.7yrsno datano data

6.9yrs

Average Tenure

64yo

Average Age

Experienced Board: BTCY's board of directors are considered experienced (6.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.